Timothy N. Showalter

5.1k total citations
215 papers, 3.5k citations indexed

About

Timothy N. Showalter is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Timothy N. Showalter has authored 215 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Pulmonary and Respiratory Medicine, 81 papers in Radiation and 53 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Timothy N. Showalter's work include Advanced Radiotherapy Techniques (81 papers), Prostate Cancer Diagnosis and Treatment (75 papers) and Prostate Cancer Treatment and Research (58 papers). Timothy N. Showalter is often cited by papers focused on Advanced Radiotherapy Techniques (81 papers), Prostate Cancer Diagnosis and Treatment (75 papers) and Prostate Cancer Treatment and Research (58 papers). Timothy N. Showalter collaborates with scholars based in United States, Canada and United Kingdom. Timothy N. Showalter's co-authors include Adam P. Dicker, Nitin Ohri, Daniel M. Trifiletti, Edouard J. Trabulsi, Mark V. Mishra, Nicholas G. Zaorsky, Xinglei Shen, Bruce Libby, Leonard G. Gomella and Robert B. Den and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Timothy N. Showalter

206 papers receiving 3.5k citations

Peers

Timothy N. Showalter
Mitchell Kamrava United States
Kyung Hwan Shin South Korea
Michael Poulsen Australia
Erqi L. Pollom United States
Matthew Koshy United States
Bhadrasain Vikram United States
Mitchell Kamrava United States
Timothy N. Showalter
Citations per year, relative to Timothy N. Showalter Timothy N. Showalter (= 1×) peers Mitchell Kamrava

Countries citing papers authored by Timothy N. Showalter

Since Specialization
Citations

This map shows the geographic impact of Timothy N. Showalter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy N. Showalter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy N. Showalter more than expected).

Fields of papers citing papers by Timothy N. Showalter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy N. Showalter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy N. Showalter. The network helps show where Timothy N. Showalter may publish in the future.

Co-authorship network of co-authors of Timothy N. Showalter

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy N. Showalter. A scholar is included among the top collaborators of Timothy N. Showalter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy N. Showalter. Timothy N. Showalter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tward, Jonathan D., Huei–Chung Huang, Andre Esteva, et al.. (2024). Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology. JCO Precision Oncology. 8(8). e2400145–e2400145. 5 indexed citations
2.
Aliotta, Eric, et al.. (2024). Predicting radiation‐induced immune suppression in lung cancer patients treated with stereotactic body radiation therapy. Medical Physics. 51(9). 6485–6500. 4 indexed citations
3.
Canavan, Maureen, Xiaoliang Wang, Mustafa Ascha, et al.. (2024). Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors. JAMA Oncology. 10(7). 887–887. 12 indexed citations
5.
Sutera, Philip, Matthew P. Deek, Adrianna A. Mendes, et al.. (2024). Validation of a Digital Pathology-Based Multimodal Artificial Intelligence Model in Oligometastatic Castration-Sensitive Prostate Cancer, including in Patients from the STOMP and ORIOLE Phase II Randomized Clinical Trials. International Journal of Radiation Oncology*Biology*Physics. 120(2). S133–S133.
6.
8.
Meneveau, Max O., et al.. (2022). Factors Associated With Cosmetic Outcomes After Treatment With a Novel Form of Breast Intraoperative Radiation Therapy. Journal of Surgical Research. 283. 514–522.
10.
Aliotta, Eric, et al.. (2022). Dose differentiated high-dose-rate prostate brachytherapy: a feasibility assessment of MRI-guided dose escalation to dominant intra-prostatic lesions. Journal of Contemporary Brachytherapy. 14(5). 423–428. 1 indexed citations
11.
Wages, Nolan A., Sunil W. Dutta, Quan Chen, et al.. (2020). STAT RAD: Prospective Dose Escalation Clinical Trial of Single Fraction Scan-Plan-QA-Treat Stereotactic Body Radiation Therapy for Painful Osseous Metastases. Practical Radiation Oncology. 10(6). e444–e451. 11 indexed citations
12.
Meneveau, Max O., Gina R. Petroni, Nikole Varhegyi, et al.. (2020). Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT. Brachytherapy. 19(5). 679–684. 11 indexed citations
13.
Zaorsky, Nicholas G., Timothy N. Showalter, Gary A. Ezzell, et al.. (2016). ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II. Advances in Radiation Oncology. 2(1). 62–84. 32 indexed citations
14.
Trifiletti, Daniel M., Timothy N. Showalter, & Lois Shepherd. (2015). What Is Reasonably Foreseeable? Lessons Learned From the SUPPORT Trial. International Journal of Radiation Oncology*Biology*Physics. 92(4). 718–720. 3 indexed citations
15.
Yamoah, Kosj, Timothy N. Showalter, & Nitin Ohri. (2015). Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials. International Journal of Radiation Oncology*Biology*Physics. 93(4). 737–745. 38 indexed citations
16.
Yamoah, Kosj, Harriet Eldredge-Hindy, Nicholas G. Zaorsky, et al.. (2014). Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 13(5). 456–464. 7 indexed citations
17.
Buzurović, Ivan, Timothy N. Showalter, Matthew T. Studenski, et al.. (2013). Commissioning and implementation of an implantable dosimeter for radiation therapy. Journal of Applied Clinical Medical Physics. 14(2). 234–252. 6 indexed citations
18.
Mishra, Mark V., Timothy N. Showalter, & Adam P. Dicker. (2012). Biomarkers of Aging and Radiation Therapy Tailored to the Elderly: Future of the Field. Seminars in Radiation Oncology. 22(4). 334–338. 5 indexed citations
19.
Mishra, Mark V., Xinglei Shen, Robert B. Den, et al.. (2012). Patterns of Care for Elderly Men Diagnosed With Favorable-risk Prostate Cancer From 2004 to 2008. American Journal of Clinical Oncology. 36(6). 606–611. 9 indexed citations
20.
Showalter, Timothy N., Barry A. Siegel, Jeffrey F. Moley, Thomas Baranski, & Perry W. Grigsby. (2008). Prognostic Factors in Patients with Well-Differentiated Thyroid Cancer Presenting with Pulmonary Metastasis. Cancer Biotherapy and Radiopharmaceuticals. 23(5). 655–660. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026